histor
sourc
use
glycyrrhiza
speci
includ
ancient
manuscript
china
india
greec
mention
use
symptom
viral
respiratori
tract
infect
hepat
random
control
trial
confirm
glycyrrhiza
glabra
deriv
compound
glycyrrhizin
deriv
reduc
hepatocellular
damag
chronic
hepat
b
c
futur
research
need
explor
potenc
compound
deriv
licoric
prevent
treatment
influenza
viru
pneumonia
adjuv
treatment
patient
infect
hiv
resist
antiretrovir
drug
glycyrrhiza
glabra
perenni
herb
nativ
central
southwestern
asia
well
mediterranean
region
cultiv
temper
subtrop
region
world
includ
europ
asia
root
dri
process
call
licoric
characterist
odour
sweet
tast
licoric
deriv
greek
word
sweet
root
licoric
one
wide
use
medicin
plant
found
tradit
formula
sinc
antiqu
armanini
et
al
fior
et
al
use
plant
trace
back
ancient
assyrian
egyptian
chines
indian
cultur
appreci
ancient
greek
roman
licoric
use
arab
medicin
middl
age
document
canon
ibn
sina
ad
summari
hippocr
galen
medicin
sourc
mention
use
symptom
attribut
viral
respiratori
tract
infect
dri
cough
hoars
voic
symptom
hepat
past
year
use
glycyrrhiza
compound
antiqu
tradit
herbal
medicin
investig
scientif
main
chemic
constitu
licoric
root
triterpen
saponin
glycyrrhizin
major
compon
concentr
vari
depend
speci
geograph
locat
method
extract
barn
et
al
blumenth
et
al
glycyrrhizin
glycosid
occur
mixtur
calcium
sodium
potassium
salt
glycyrrhizin
acid
also
name
glycyrrhiz
acid
fig
hydrolysi
releas
two
molecul
dglucuron
acid
aglycon
acid
also
call
glycyrrhet
acid
pentacycl
triterpen
deriv
type
robber
et
al
blumenth
et
al
evan
baltina
aim
review
summar
data
medic
research
effect
licoricederiv
compound
viral
infect
correspond
vitro
data
analys
underli
mechan
licoric
extract
viral
hepat
random
control
trial
glycyrrhizin
usual
administ
intraven
induc
signific
reduct
serum
liver
enzym
caus
improv
liver
histolog
comparison
placebo
among
recent
studi
effect
formul
stronger
neominophagen
c
snmc
contain
mg
glycyrrhizin
administ
inject
patient
chronic
viral
hepat
mention
formul
evalu
differ
dose
frequenc
administr
overal
shortterm
therapeut
respons
consist
dosedepend
effect
suppress
alanin
aminotransferas
alt
level
patient
chronic
viral
hepat
miyak
et
al
snmc
although
without
specif
activ
hepat
viru
show
antiinflammatori
effect
abl
improv
clinic
condit
patient
liver
diseas
variou
stage
acharya
et
al
glycyrrhizin
use
treat
chronic
hepat
b
viru
infect
drug
may
improv
liver
function
occasion
complet
recoveri
hepat
takahara
et
al
sato
et
al
daili
intraven
administr
ml
glycyrrhizincontain
prepar
snmc
week
safe
efficaci
treatment
lower
normal
alt
level
patient
chronic
hepat
b
zhang
wang
intraven
administr
year
glycyrrhizin
acid
patient
chronic
viral
hepat
b
abl
produc
posit
effect
evolut
diseas
success
rate
compar
result
obtain
interferon
eisenburg
patient
chronic
hepat
c
glycyrrhizin
shown
reduc
transaminas
level
random
phase
ii
trial
orient
et
al
follow
use
snmc
retrospect
studi
conduct
japan
order
evalu
effect
glycyrrhizin
hepatocellular
carcinoma
develop
aras
et
al
patient
diagnos
chronic
hepat
c
group
patient
treat
snmc
ml
daili
week
time
week
year
median
year
anoth
group
patient
treat
snmc
interferon
long
period
time
median
year
receiv
herbal
medicin
includ
vitamin
k
rate
cumul
hepatocellular
carcinoma
incid
two
group
respect
indic
rel
risk
estim
multivari
cox
regress
analysi
confid
interv
p
patient
treat
snmc
aras
et
al
result
later
confirm
anoth
longitudin
cohort
studi
conduct
year
ml
median
daili
dose
snmc
inject
intraven
daili
median
period
year
crude
carcinogenesi
rate
year
treat
untreat
group
respect
p
proport
hazard
analysi
disclos
glycyrrhizin
significantli
decreas
hepatocarcinogenesi
rate
hazard
ratio
confid
interv
ikeda
et
al
basi
clinic
histolog
marker
conclud
snmc
suppress
liver
necrosi
inflamm
patient
chronic
hepat
c
suggest
longterm
treatment
product
might
use
prevent
liver
cirrhosi
hepatocellular
carcinoma
kumada
gotoh
et
al
conduct
longterm
studi
snmc
mg
glycyrrhizinkg
drip
infus
aid
patient
high
ratio
treatment
clinic
studi
count
lymphocyt
ratio
asymptomat
carrier
ac
patient
aidsrel
complex
arc
show
increas
signific
clinic
improv
achiev
almost
half
treat
patient
gotoh
et
al
result
confirm
anoth
studi
mori
et
al
haemophilia
patient
hiv
infect
ac
statu
author
found
glycyrrhizin
possess
inhibitori
effect
hiv
replic
also
interferoninduc
natur
killer
nk
enhanc
effect
author
conclud
administr
glycyrrhizin
hivposit
hemophilia
patient
seem
effect
prevent
develop
aid
rais
number
tlymphocyt
mori
et
al
effect
influenza
mous
model
princip
compon
licoric
glycyrrhizin
evalu
experiment
mous
model
influenza
viru
utsonomiya
et
al
mice
treat
intraperiton
mg
glycyrrhizinkg
bodi
weight
day
exposur
ld
lethal
dose
kill
anim
influenza
viru
day
infect
anim
surviv
experiment
period
day
convers
mean
surviv
time
control
mice
day
survivor
grade
pulmonari
consolid
viru
titer
lung
tissu
infect
mice
treat
glycyrrhizin
significantli
lower
lung
tissu
infect
mice
treat
salin
interest
find
splenic
cell
glycyrrhizintr
mice
transfer
mice
expos
influenza
viru
recipi
surviv
survivor
seen
recipi
mice
inocul
nativ
cell
splenic
b
cell
macrophag
glycyrrhizintr
mice
administr
glycyrrhizin
infect
mice
combin
antigamma
interferon
monoclon
antibodi
produc
antivir
effect
result
obtain
author
indic
glycyrrhizin
may
protect
mice
expos
lethal
dose
influenza
viru
induct
interferongamma
product
cell
utsonomiya
et
al
previous
report
studi
indic
mice
glycyrrhizin
glycyrrhetin
acid
abl
induc
product
interferon
abe
et
al
suggest
possibl
mechan
action
viral
infect
effect
murin
herp
enceph
antivir
effect
glycyrrhizin
evalu
murin
herp
enceph
sekizawa
et
al
intraperiton
administr
glycyrrhizin
increas
surviv
rate
anim
time
viral
replic
brain
reduc
control
first
report
antivir
properti
licoric
constitu
date
year
pompei
et
al
follow
screen
investig
plant
extract
author
found
compon
licoric
root
identifi
glycyrrhiz
acid
antivir
activ
inhibit
growth
cytopath
effect
sever
dna
rna
virus
vaccinia
herp
simplex
type
newcastl
diseas
vesicular
stomat
virus
vitro
drug
affect
cell
activ
concentr
glycyrrhiz
acid
abl
inhibit
growth
cytopath
effect
virus
rang
mm
ad
infect
cell
cultur
soon
incub
pompei
et
al
effect
herpesvirida
follow
landmark
studi
glycyrrhizin
evalu
vitro
antivir
action
varicellazost
viru
baba
shigeta
human
embryon
fibroblast
cell
inocul
five
strain
viru
glycyrrhizin
produc
inhibitori
effect
viral
prolifer
ic
inhibitori
concentr
reduc
activ
control
mm
select
index
defin
ratio
ic
hostcel
dna
synthesi
ic
viru
replic
estim
valu
high
commonli
use
antivir
drug
select
index
acyclovir
close
machida
et
al
pretreat
cell
drug
h
inocul
abl
inhibit
replic
viru
incub
viru
min
concentr
mm
glycyrrhizin
effect
inactiv
viru
particl
glycyrrhizin
demonstr
addit
effect
convent
antivir
drug
acyclovir
also
human
betainterferon
studi
demonstr
inhibit
glycyrrhiz
acid
vitro
synerg
inhibitori
effect
endogen
antivir
substanc
lactoferrin
found
lampi
et
al
effect
glycyrrhiz
acid
also
report
epsteinbarr
viru
ebv
produc
infecti
mononucleosi
lin
inhibit
ebv
replic
vitro
dosedepend
ic
valu
viral
inhibit
cell
growth
mm
respect
select
index
lin
suggest
drug
interfer
earli
step
ebv
replic
possibl
penetr
without
effect
viral
adsorpt
inactiv
lin
investig
effect
glycyrrhizin
cytomegaloviru
infect
human
monocyt
human
embryon
lung
cell
line
show
inhibit
viral
antigen
express
numazaki
et
al
new
strategi
cure
influenza
need
sinc
convent
antivir
agent
amantadin
ribavirin
effect
toxic
side
effect
glycyrrhiz
acid
shown
inhibit
recoveri
hemagglutinin
influenza
virusinfect
embryon
hen
egg
pompei
et
al
substanc
affect
viral
viabil
impair
hemagglutin
activ
virion
abl
affect
growth
virus
embryon
tissu
particularli
late
viral
replic
step
recent
studi
ko
et
al
conduct
use
glycyrrhiza
uralensi
ethanol
extract
cultur
human
bronchial
epitheli
cell
infect
influenza
viru
extract
produc
inhibitori
effect
product
rant
potent
chemotact
cytokin
monocyt
basophil
cell
typic
detect
nasal
secret
patient
upper
respiratori
tract
infect
involv
epitheli
cellmedi
inflammatori
process
licoric
extract
evalu
concentr
rang
maxim
concentr
inhibit
rant
product
observ
ko
et
al
suggest
compound
deriv
glycyrrhiza
spp
may
benefici
treatment
inflammatori
process
relat
viral
infect
effect
glycyrrhizin
amelior
chronic
hepat
indic
reduct
plasma
aspart
aminotransferas
ast
alanin
aminotransferas
alt
activ
patient
chronic
hepat
van
rossum
et
al
demonstr
experiment
investig
anim
cell
shiki
et
al
shibata
hepat
b
virustat
effect
could
depend
inhibit
intrahepat
transport
sialyl
hepat
bviru
hbv
surfac
antigen
hbsag
observ
vitro
sato
et
al
isol
rat
hepatocyt
glycyrrhizin
suppress
releas
transaminas
presenc
either
antiliv
cell
membran
antibodi
phospholipas
shiki
et
al
result
indic
treatment
liver
cell
antibodi
activ
phospholipas
cell
membran
lead
disintegr
cell
membran
cell
death
result
releas
transaminas
glycyrrhizin
suppress
increas
phospholipas
activ
inhibit
releas
transaminas
demonstr
anticytolyt
effect
shiki
et
al
result
vitro
anim
rat
studi
support
glycyrrhizin
inhibit
lipid
peroxid
therebi
protect
rat
hepatocyt
kiso
et
al
jeong
et
al
shown
glycyrrhizin
inhibit
immunomedi
cytotox
hepatocyt
murin
activ
murin
liver
injuri
induc
ccl
moreov
glycyrrhizin
inhibit
antifa
antibodyinduc
elev
alt
mice
shibata
anoth
group
demonstr
glycyrrhizin
reduc
alt
level
steatosi
fibrosi
mous
model
liver
injuri
induc
ccl
ethanol
experi
show
concomit
reduc
nuclear
factorkappa
b
bind
wang
et
al
vitro
experi
demonstr
glycyrrhizin
suppress
secret
hepat
b
surfac
antigen
hbsag
inhibit
intracellular
transport
hbsag
transgolgi
area
olink
glycosyl
sialyl
takahara
et
al
studi
confirm
glycyrrhizin
bind
hepatocyt
modifi
express
hbvrelat
antigen
hepatocyt
suppress
sialyl
hbsag
sato
et
al
glycyrrhizin
immunomodulatori
agent
given
intraven
combin
lamivudin
also
use
treatment
subacut
hepat
due
hepat
b
tandon
et
al
cranc
et
al
cranc
et
al
found
complet
concentrationdepend
inhibit
express
hepat
viru
hav
antigen
hav
infect
glycyrrhizin
human
hepatoma
cell
line
mechan
antivir
effect
inhibit
penetr
endocytosi
liver
cell
propos
mechan
induct
decreas
neg
charg
cell
surfac
andor
decreas
membran
fluiditi
cell
sensit
hiv
fuse
giant
cell
infect
provid
paramet
determin
cytopath
effect
hiv
ito
et
al
baba
et
al
glycyrrhizin
sulphat
found
inhibit
cellfre
viral
infect
cell
cell
infect
tochikura
et
al
effect
may
due
abil
reduc
membran
fluiditi
reduc
membran
fluiditi
glycyrrhizin
could
explain
inhibit
celltocel
fusion
suppress
format
virolog
synaps
harada
found
revers
transcriptas
rrt
function
effect
phosphat
acceptor
recombin
human
casein
kinas
ii
rhckii
vitro
phosphoryl
inhibit
glycyrrhetin
acid
deriv
quercetin
high
dose
glycyrrhizin
rnadepend
dnapolymeras
rddp
activ
stimul
full
phosphoryl
rrt
rhckii
harada
et
al
recent
investig
evalu
effect
glycyrrhizin
hiv
replic
cultur
peripher
blood
mononuclear
cell
pbmc
hivinfect
patient
sasaki
et
al
sasaki
et
al
sampl
glycyrrhizin
inhibit
hiv
replic
includ
nonsyncytiuminduc
variant
hiv
nsihiv
glycyrrhizin
induc
product
cc
chemokin
ligand
ccl
dosedepend
manner
suggest
drug
possess
potenti
inhibit
nsihiv
stimul
product
betachemokin
sasaki
et
al
sasaki
et
al
compet
chemokin
receptor
mediat
infect
cell
hiv
among
varieti
natur
product
describ
antihiv
agent
glycyrrhizin
found
mechan
action
may
least
part
attribut
interfer
viruscel
bind
de
clercq
recent
increas
quantiti
data
suggest
antivir
effect
glycyrrhizin
link
induct
endogen
interferon
gamma
thyagarajan
et
al
glycyrrhizin
affect
cellular
signal
pathway
protein
kinas
ii
casein
kinas
ii
transcript
factor
activ
nuclear
factor
wang
et
al
new
coronaviru
identifi
patient
sever
acut
respiratori
syndrom
sar
diseas
drawn
enorm
attent
caus
fear
worldwid
sinc
earli
although
diseas
control
possibl
return
patholog
stimul
search
remedi
sever
studi
report
specif
treatment
sar
yet
establish
variou
pharmacolog
treatment
suggest
steroid
ribavirin
interferon
also
glycyrrhizin
fujii
et
al
chen
et
al
glycyrrhizin
inhibit
sarsassoci
coronaviru
sarscov
replic
vero
cell
select
index
cinatl
et
al
addit
inhibit
viru
replic
glycyrrhizin
abl
inhibit
adsorpt
penetr
viru
earli
step
replic
cycl
activ
glycyrrhizin
lower
ad
adsorpt
period
viru
adsorpt
ec
mgl
vs
mgl
respect
glycyrrhizin
found
effect
given
adsorpt
period
mechan
activ
glycyrrhizin
sarscov
unclear
studi
cinatl
et
al
show
glycyrrhizin
induc
nitrou
oxid
synthas
vero
cell
viru
replic
inhibit
nitrou
oxid
donor
deta
nonoat
ad
cultur
medium
sinc
glycyrrhizin
shown
abl
inhibit
sarscov
replic
vitro
activ
sever
glycyrrhiz
acid
deriv
evalu
hoever
et
al
introduct
glycosid
chain
glycyrrhizin
produc
increas
antisarscov
activ
compound
amid
conjug
glycyrrhizin
two
amino
acid
residu
present
increas
activ
viru
hoever
et
al
howev
cytotox
increas
well
deriv
result
decreas
select
index
effect
virus
glycyrrhizin
test
vitro
antivir
activ
sever
pathogen
flavivirus
involv
diseas
dengu
japanes
enceph
mammalian
tickborn
enceph
yellow
fever
cranc
et
al
glycyrrhizin
found
abl
inhibit
replic
flavivirus
badam
target
glycyrrhizin
action
vesicular
stomat
viru
vsv
identifi
enzym
kinas
p
ohtsuki
iahida
essenti
earli
stage
viral
replic
glycyrrhizin
low
dose
found
select
inhibit
protein
phosphoryl
kinas
p
without
signific
effect
kinas
report
direct
bind
glycyrrhizin
virusassoci
kinas
result
inactiv
reduct
viral
infect
ohtsuki
iahida
recent
glycyrrhiza
contain
glycyrrhiz
acid
found
inhibit
cytopath
effect
respiratori
syncyti
viru
hela
cell
wang
et
al
recent
demonstr
treatment
glycyrrhiz
acid
cell
latent
infect
kaposi
sarcomaassoci
herpesviru
kshv
abl
reduc
synthesi
viral
latenc
protein
induc
apoptosi
infect
cell
curr
et
al
find
suggest
glycyrrhiz
acid
may
key
find
novel
way
interrupt
latenc
infect
cell
cohen
toxic
effect
licoric
extract
glycyrrhizin
compound
well
studi
document
human
past
year
report
advers
effect
glycyrrhizin
includ
aldosteronelik
effect
pseudohyperaldosteron
relat
inhibit
convers
cortisol
cortison
associ
hypokalemia
hypertens
decreas
plasma
renin
aldosteron
level
myopathi
oedema
andor
muscl
weak
peopl
take
excess
amount
glycyrrhizin
contain
product
accept
daili
intak
avoid
effect
determin
mgkg
glycyrrhizin
heavi
consumpt
licoric
also
associ
increas
risk
preterm
birth
crosssect
retrospect
studi
isbruck
burdock
threat
global
public
health
pandem
viral
diseas
like
induc
influenza
hiv
virus
requir
urgent
evalu
herbal
drug
show
promis
tradit
herbal
medicin
lack
effect
drug
influenza
viru
increas
problem
multiresist
hiv
infect
make
glycyrrhiza
spderiv
compound
import
candid
drug
develop
data
review
show
sever
constitu
licoric
root
potenti
effect
altern
combat
wide
varieti
respiratori
hepat
system
viral
diseas
gener
immun
modulatori
membran
effect
well
specif
effect
enzym
activ
express
relat
select
virus
see
tabl
view
safeti
profil
establish
japanes
trial
patient
viral
hepat
random
control
trial
dose
find
studi
prevent
treatment
influenza
viru
hiv
infect
justifi
futur
trial
need
address
potenti
side
effect
report
licoric
use
particularli
elderli
peopl
heart
diseas
diuret
medic
vitro
studi
work
chemic
modifi
deriv
greater
activ
increas
select
indic
requir
takahara
et
al
sato
et
al
eisenburg
tandon
et
al
sato
et
al
shiki
et
al
